Yesim Yildiz

Yesim Yildiz

Auto-generated profile, based on publicly available information

Yesim Yildiz

Spine Center, Cantonal Hospital St. Gallen, HOCH Health Ostschweiz & University of St. Gallen, 9000 St. Gallen, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YYYesim Yildiz
Yesim Yildiz
SMStefan Motov
Stefan Motov
FSFelix Stengel
Felix Stengel
LBLorenzo Bertulli
Lorenzo Bertulli
GFGregor Fischer
Gregor Fischer
NHNader Hejrati
Nader Hejrati
Background/Objectives: The concept of frailty has been recognized as an important issue which can influence postoperative outcomes. We aimed to investigate the influence of frailty on clinical and radiological outcomes in patients undergoing transforaminal lumbar interbody fusion (TLIF) for degenerative spine disease. Methods: A single-center, retrospective cohort study was conducted involving 408 patients in whom 506 expandable interbody devices were implanted. The patients were grouped into vulnerable/frail versus well/fit according to the Canadian Frailty Index. Results: The frail patients were older and had a larger number of fused segments (3.0 vs. 2.4 segments, p = 0.009). In the univariate analysis, the frail patients were more likely to experience a postoperative adverse event (AE) until discharge (OR 1.89, 95% CI 1.22–2.92; p = 0.004), three (OR 1.57, 1.07–2.3; p = 0.021), and 12 months postoperatively (OR 3.77, 1.96–7.24; p < 0.001). Following the multivariable logistic regression analysis, frailty remained an independent risk factor for postoperative AEs at 12 months (OR 3.44, 95% CI 1.69–6.99; p = 0.001). Conclusions: Frailty negatively influenced the rate of AEs until 12 months, while the odds of having a favorable outcome at any time remained unaffected in patients undergoing posterior spinal fusion with TLIF. Future efforts are needed to evaluate whether preoperative medical optimization or prehabilitation may positively impact patient outcomes.

4 July 2025 in Brain and Spine
Verified
Journal Article
Open access
Martin N. StienenMartin N. Stienen
Martin N. Stienen
LBLorenzo Bertulli
Lorenzo Bertulli
LBLinda Bättig
Linda Bättig
YYYesim Yildiz
Yesim Yildiz
GFGregor Fischer
Gregor Fischer
BMBenjamin Martens
Benjamin Martens
Subsidence of transforaminal lumbar interbody fusion (TLIF) cages is a common complication. Little is known about risk factors for cage subsidence (CS) of expandable spacers. To develop a score for CS risk stratification. We reviewed consecutive patients treated by TLIF with a specific type of expandable interbody implant. CS at the 3-month follow-up was defined as primary endpoint. We identified risk factors, calculated their effect sizes using multivariable logistic regression models and developed the Expandable TLIF Subsidence Index (ETSI). Area Under the Receiver Operating Curve (AUROC) was performed. We identified n = 388 patients (mean age 64.8 years, 55.9 % female), in which we performed TLIF at 482 levels. CS at 3 months was evident in n = 123 patients and on 153 levels (31.7 %). Independent risk factors for CS were high ASA score (3&4; odds ratio (OR) 2.19, 95 % confidence interval (CI) 1.37–3.50, p = 0.008), indication for surgery other than degenerative or deformity (4.79, 1.75–13.1, p = 0.002), lower lumbar spine (L3/4-L5/S1; 4.31, 1.46–12.7, p = 0.008), small cage size (1.94, 1.22–3.07, p = 0.005), and more posterior position of the cage in the intervertebral space (1.68, 1.15–2.43, p = 0.007). The ETSI with a range from -2-6 points obtained an AUROC of 0.6807, indicating a moderate classification result. For each 1-step increase in the ETSI, an OR of 2.02 (1.63–2.50, p < 0.001) to develop CS was calculated and it predicted 3- and 12-month non-union risk. We identified risk factors for CS, some of which have strong effect sizes and are potentially modifiable.

3 February 2026 in Brain and Spine
Verified
Journal Article
Open access
FCFelix Corr
Felix Corr
FKFaizan Kareem
Faizan Kareem
LBLinda Bättig
Linda Bättig
BCBenedict Caspari
Benedict Caspari
KKKarl Kapahnke
Karl Kapahnke
SMStefan Motov
Stefan Motov
Power-drill fluoroscopy-controlled freehand (PFH) pedicle screw placement is a drill-based refinement of the freehand technique that combines fluoroscopic control with tactile feedback. Its performance in degenerative spine surgery remains underexplored. This study compared the accuracy and procedural characteristics of PFH and navigation-assisted (NA) screw placement in thoracolumbar posterior fusion. To investigate whether PFH pedicle screw placement achieves comparable accuracy to NA techniques in degenerative thoracolumbar fusion surgery. Adults undergoing elective thoracolumbar fusion with PFH or NA pedicle screw placement were retrospectively analyzed. Propensity score matching balanced demographic and clinical variables between groups. Screw accuracy was graded by the Gertzbein–Robbins Scale (GRS). Secondary outcomes included radiation exposure and perioperative variables. A generalized linear mixed model accounted for multiple screws per patient. After matching, 35 patients per group were analyzed (PFH, 224 screws; NA, 154 screws). Satisfactory screw placement was achieved in 97.8% of PFH and 93.5% of NA screws (p = 0.02). Revision rates within 12 months were similar (5.7% vs 17.1%; p = 0.26). Radiation exposure was lower with PFH (8378 ± 5302 vs 23,793 ± 13,162 mGy cm2; p < 0.001), despite longer constructs and more frequent cement utilization. Osteoporosis independently reduced accuracy (OR 0.43; 95% CI, 0.20–0.92; p = 0.02). In this propensity-matched analysis, PFH demonstrated accuracy comparable to NA (absolute difference 4.3 percentage points) with significantly lower patient radiation exposure. Further investigations are needed to justify the PFH method as a potential alternative in selected degenerative cases where radiation reduction is prioritized or navigation is unavailable.

1 May 2026 in Brain and Spine
Verified
Journal Article
Open access
Martin N. StienenMartin N. Stienen
Martin N. Stienen
LFLaurin Feuerstein
Laurin Feuerstein
FSFelix C. Stengel
Felix C. Stengel
LBLorenzo Bertulli
Lorenzo Bertulli
LBLinda Bättig
Linda Bättig
BMBenjamin Martens
Benjamin Martens
Transforaminal lumbar interbody fusion (TLIF) can be extended by transforaminal anterior release (TFAR), to open and distract degenerated segments and increase segmental lordosis (SL). To analyze the rate, type and severity of adverse events (AEs), as well as spinopelvic parameters and clinical outcomes. We reviewed consecutive patients treated with TLIF with expandable interbody spacers. TFAR patients were matched 1:5 to a control group (conventional TLIF). We identified n = 435 patients (541 TLIF levels; mean age 65.2 years; 55.7% female), of which n = 30 patients (39 levels) were assigned to the TFAR group and n = 149 (247 TLIF levels) to the control group. TFAR procedures took longer (mean difference (MD) 86min, p = 0.004) and had a higher blood loss (MD 463 ml, p = 0.022). In multivariable analysis, TFAR patients were more likely to experience intraoperative AEs (OR 3.49, 95% CI 1.47 – 8.31, p = 0.005) and early postoperative AEs (OR 2.39, 95% CI 0.99 – 5.76, p = 0.051), while the risk for further AEs at 90 days and 12 months was similar. Patients in the TFAR group were more likely to achieve a favorable 12-month outcome (OR 2.71, 95% CI 1.13 – 6.51, p = 0.025). TFAR patients had consistently more SL during follow-up (12 month: 24.9° vs. 18.9°, p < 0.001) and the pelvic incidence (PI)-LL mismatch was lower (0.4° vs. 7.2°, p = 0.020). We found a 3-fold increase in intraoperative and early postoperative AEs in TFAR patients, while the mid- and longer-term outcomes were similar or even slightly better than in patients undergoing conventional TLIF.

Verified
Journal Article
Open access
PDF file
Martin N. StienenMartin N. Stienen
Martin N. Stienen
LBLorenzo Bertulli
Lorenzo Bertulli
GFGregor Fischer
Gregor Fischer
LBLinda Bättig
Linda Bättig
YYYesim Yildiz
Yesim Yildiz
NHNader Hejrati
Nader Hejrati
Background: Transforaminal lumbar interbody fusion (TLIF) with static cages is a frequently performed procedure. Larger series focusing on the use of expandable TLIF spacers are less common. Methods: This retrospective, single-center observational cohort study reviewed consecutive patients treated by TLIF using expandable titanium interbody implants (ALTERA™, Globus Medical Inc., Audubon, PA, USA) for degenerative pathologies from L2-S1 between 11/2018 and 09/2023. Surgical parameters, adverse events, radiological outcomes (fusion rate, segmental lordosis, spinopelvic parameters), and clinical outcomes were analyzed through a mean postoperative follow-up of 12 months. Results: This study identified 270 patients (mean age 65 years, 50.4% female) who underwent TLIF with expandable interbody spacers at 324 levels. Clinical outcomes were good or excellent in 74.1% of patients at 3 months and 71.8% at 12 months. Radiographic fusion was achieved in 73.1% of assessable segments at 12 months. Segmental lordosis increased significantly from 17.8° preoperatively to 20.0° at 12 months (p < 0.001). Adverse event (AE) rates were acceptable across all timepoints, with no device failures or device-associated complications observed. Conclusions: This study demonstrates that TLIF with expandable titanium interbody implants was safe, associated with high fusion rates, and enabled significant restoration of segmental lordosis that was maintained during follow-up.